- Home
- EM vs FENC Comparison
EM vs FENC Comparison
Compare EM & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EM | FENC |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 276.3M |
| IPO Year | 2021 | 2001 |
Fundamental Metrics
Financial Performance| Metric | EM | FENC |
|---|---|---|
| Price | $1.15 | $7.68 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.25 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 805.9K | 183.3K |
| Earning Date | 03-27-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $259,541,587.00 | $38,790,000.00 |
| Revenue This Year | $3.30 | N/A |
| Revenue Next Year | $5.26 | $70.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.68 | $4.68 |
| 52 Week High | $1.46 | $9.92 |
Technical Indicators
Market Signals| Indicator | EM | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 22.22 | 47.61 |
| Support Level | $1.13 | $7.51 |
| Resistance Level | $1.19 | $8.16 |
| Average True Range (ATR) | 0.04 | 0.33 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 8.49 | 36.24 |
Price Performance
Historical ComparisonAbout EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.